Journal for Immunotherapy of Cancer

The Journal for ImmunoTherapy of Cancer, the official journal of the Society for Immunotherapy of Cancer (SITC), is an open access, peer-reviewed journal with a 2020 impact factor of 13.751.

Access 2020 Articles

• Original Research: “Transgenic CD8αβ co-receptor rescues endogenous TCR function in TCR-transgenic virus-specific T cells"
• Original Research: “Sensitive manipulation of CAR T cell activity using a chimeric endocytosing receptor"
• Position article and guideline: "Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma"

Top Accessed 2019 Articles

• Research Article: PD-1 silencing impairs the anti-tumor function of chimeric antigen receptor modified T cells by inhibiting proliferation activity
• Research Article: A rare population of tumor antigen-specific CD4+CD8+ double-positive αβ T lymphocytes uniquely provide CD8-independent TCR genes for engineering therapeutic T cells 
• Research Article: Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer 

ACCESS THE FULL JOURNAL

SITC Consensus Statements, Guidelines and White Papers

• Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events
• Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma (2020)
• The Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia (2020)
• The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma (2020)
• The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia (2016)

• Immune Checkpoint Inhibitor-related Adverse Events
  • SITC Clinical Practice Guideline Webinar – Immune Checkpoint Inhibitor-related Adverse Events: August 13, 2021, 10 AM - 11 AM ET
  • SITC Clinical Practice Guideline Webinar – Practical Management Pearls for Immune Checkpoint Inhibitor-related Adverse Events: September 16, 2021, 11:30 AM - 12:30 PM ET
  • SITC Clinical Practice Guideline Webinar – Case Studies in Immune Checkpoint Inhibitor-related Adverse Events: October 6, 2021, 7 PM - 8 PM ET

Textbook

Cancer Immunotherapy Principles and Practice is an authoritative textbook to cancer immunobiology and the immunotherapy treatments that harness the immune system to combat malignant disease. This comprehensive reference work covers all major topics that have shaped the development of immunotherapy and propelled it to its current place at the forefront of cancer treatment innovation.

Section 1: Basic Principles of Tumor Immunology

• Chapter 9: The Innate Immune System: Natural Killer Cells
• Chapter 11: Natural Killer Cell Effector Mechanisms Against Solid Tumors and Leukemias and Their Exploitation in Immunotherapy

Section 5: Regulatory Aspects of Cancer Immunotherapy

• Chapter 53: A Regulatory Perspective on Cell Therapy for Cancer

PURCHASE THE TEXTBOOK